ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 200,000 Value ($000) $4,094 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 200,000 Value ($000) $4,012 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 250,000 Value ($000) $4,920 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 250,000 Value ($000) $5,625 Avg Close $25.92 Range $21.43 - $30.03

Q3 2023

Shares 1,216,712 Value ($000) $16,620 Avg Close $16.84 Range $12.38 - $20.77

Q2 2023

Shares 1,936,133 Value ($000) $39,516 Avg Close $20.21 Range $17.15 - $23.98

Q1 2023

Shares 1,936,133 Value ($000) $42 Avg Close $20.34 Range $14.56 - $25.34

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	200,000	$4,094	$20.16	$17.43 - $24.38
Q2 2025	200,000	$4,012	$18.93	$13.30 - $24.11
Q1 2025	250,000	$4,920	$21.52	$18.67 - $25.37
Q4 2024	250,000	$5,625	$25.92	$21.43 - $30.03
Q3 2023	1,216,712	$16,620	$16.84	$12.38 - $20.77
Q2 2023	1,936,133	$39,516	$20.21	$17.15 - $23.98
Q1 2023	1,936,133	$42	$20.34	$14.56 - $25.34